Dean A. Lee Center for Childhood Cancer and Blood Disease Nationwide Children's Hospital Biography Publications Institution JoVE Articles Dean A. Lee has not added a biography. If you are Dean A. Lee and would like to personalize this page please email our Author Liaison for assistance. Publications Aggressive Natural Killer-cell Leukemia mutational Landscape and Drug Profiling Highlight JAK-STAT Signaling As Therapeutic Target Nature Communications. Apr, 2018 | Pubmed ID: 29674644 Inhibiting TGF-beta Signaling Preserves the Function of Highly Activated, in Vitro Expanded Natural Killer Cells in AML and Colon Cancer Models PloS One. 2018 | Pubmed ID: 29342200 Ex Vivo-expanded NK Cells from Blood and Ascites of Ovarian Cancer Patients Are Cytotoxic Against Autologous Primary Ovarian Cancer Cells Cancer Immunology, Immunotherapy : CII. Apr, 2018 | Pubmed ID: 29299659 Ex Vivo-expanded Natural Killer Cells Derived From Long-term Cryopreserved Cord Blood Are Cytotoxic Against Primary Breast Cancer Cells Journal of Immunotherapy (Hagerstown, Md. : 1997). Feb/Mar, 2018 | Pubmed ID: 29189387 Venous Thromboembolism in Pediatric Hematopoietic Cell Transplant: A Multicenter Cohort Study Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Feb, 2018 | Pubmed ID: 29128552 Radiotherapy Enhances Natural Killer Cell Cytotoxicity and Localization in Pre-clinical Canine Sarcomas and First-in-dog Clinical Trial Journal for Immunotherapy of Cancer. Dec, 2017 | Pubmed ID: 29254507 Phase 1 Clinical Trial Using MbIL21 Ex Vivo-expanded Donor-derived NK Cells After Haploidentical Transplantation Blood. 10, 2017 | Pubmed ID: 28835441 Ex Vivo Expanded Natural Killer Cells from Breast Cancer Patients and Healthy Donors Are Highly Cytotoxic Against Breast Cancer Cell Lines and Patient-derived Tumours Breast Cancer Research : BCR. Jul, 2017 | Pubmed ID: 28668076 IL-18/IL-15/IL-12 Synergy Induces Elevated and Prolonged IFN-γ Production by Ex Vivo Expanded NK Cells Which is Not Due to Enhanced STAT4 Activation Molecular Immunology. Aug, 2017 | Pubmed ID: 28644973 Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines Frontiers in Immunology. 2017 | Pubmed ID: 28428785 The Histone Deacetylase Inhibitor Valproic Acid Inhibits NKG2D Expression in Natural Killer Cells Through Suppression of STAT3 and HDAC3 Scientific Reports. Mar, 2017 | Pubmed ID: 28338101 Natural Killer Cells in Malignant Hematology: A Primer for the Non-immunologist Blood Reviews. Mar, 2017 | Pubmed ID: 27665023 NK Terapia Celular: Orientación Recaída De La Enfermedad Tras El Trasplante De Células Madre Hematopoyéticas Immunotherapy. Feb, 2012 | Pubmed ID: 22329587 Unido a La Membrana IL-21 Promueve La Proliferación Sostenida Ex Vivo De Células Asesinas Naturales Humanos PloS One. 2012 | Pubmed ID: 22279576 La Infusión De CD19-células T Dirigida a Aumentar El Control De La Enfermedad En Pacientes Sometidos a Autólogo De Células Madre Hematopoyéticas Trasplante De Altos B-linfoides Malignas Human Gene Therapy. Jan, 2012 | Pubmed ID: 22107246 Reprogramación De CD19 De Células T Específicas Con La IL-21 Puede Mejorar La Señalización De La Inmunoterapia Adoptiva De Tumores Malignos Del Linaje B- Cancer Research. May, 2011 | Pubmed ID: 21558388 Adquisición, Preparación Y Funcional Evaluación De Las Células NK Humanas Para La Inmunoterapia Adoptiva Methods in Molecular Biology (Clifton, N.J.). 2010 | Pubmed ID: 20686960 Un Dispositivo De Alto Rendimiento Microelectroporation Introducir Un Receptor De Antígeno Quimérico Redirección De La Especificidad De Las Células T Humanas Biomedical Microdevices. Oct, 2010 | Pubmed ID: 20574820 La Combinación De CD19 Y La Redirección De Alloanergization Para Generar Tumores Específicos De Las Células T Humanas De Terapia Celular Alogénico De Células B Malignas Cancer Research. May, 2010 | Pubmed ID: 20424114 PiggyBac Transposón / Transposasa Sistema Para Generar CD19 De Células T Específicas Para El Tratamiento De Neoplasias Malignas De Linaje B- Human Gene Therapy. Apr, 2010 | Pubmed ID: 19905893 VEB + Enfermedad Linfoproliferativa Después De La Quimioterapia Prolongada Para La HCL Refractaria Pediatric Blood & Cancer. Mar, 2008 | Pubmed ID: 17243127 C / EBPbeta Represión Por La Interrupción Del CUGBP1 Como Resultado De Una Compleja Reordenación De MLL Cancer Genetics and Cytogenetics. Sep, 2007 | Pubmed ID: 17854664 Vacunas Contra El Rotavirus The New England Journal of Medicine. Apr, 2006 | Pubmed ID: 16625014 El Sarcoma Granulocítico Presentación De La Neumonía En Un Niño Con T (8; 21) Leucemia Mielógena Aguda: Diagnóstico Por La Hibridación Fluorescente In Situ Journal of Pediatric Hematology/oncology. Jul, 2004 | Pubmed ID: 15218417 Tumor-específicos CD4 + Células T Reguladoras Y Sus Ligandos: Implicaciones Para La Inmunoterapia Immunity. Jan, 2004 | Pubmed ID: 14738769 Periférica Activados Los Linfocitos T Sufren Apoptosis Cuando Se Cultivan Con Monocitos Activados Por El HLA De Clase II Ligadura Cellular Immunology. Oct, 2003 | Pubmed ID: 14698144 Generación de células NK humano primario y ampliado de Knock-out utilizando ribonucleoproteínas Cas9 Meisam Naeimi Kararoudi1, Hamid Dolatshad2, Prashant Trikha1, Syed-Rehan A. Hussain3, Ezgi Elmas1, Jennifer A. Foltz1, Jena E. Moseman1, Aarohi Thakkar1, Robin J. Nakkula1, Margaret Lamb1, Nitin Chakravarti1, K. John McLaughlin3, Dean A. Lee1 1Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital, 2Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, 3Center for Clinical and Translational Research, Nationwide Children's Hospital Research Institute JoVE 58237 Immunology and Infection Expansión, purificación y evaluación funcional de la sangre periférica humana células NK Srinivas S. Somanchi1, Vladimir V. Senyukov1, Cecele J. Denman1, Dean A. Lee1 1Division of Pediatrics, MD Anderson Cancer Center - University of Texas JoVE 2540 Immunology and Infection
Generación de células NK humano primario y ampliado de Knock-out utilizando ribonucleoproteínas Cas9 Meisam Naeimi Kararoudi1, Hamid Dolatshad2, Prashant Trikha1, Syed-Rehan A. Hussain3, Ezgi Elmas1, Jennifer A. Foltz1, Jena E. Moseman1, Aarohi Thakkar1, Robin J. Nakkula1, Margaret Lamb1, Nitin Chakravarti1, K. John McLaughlin3, Dean A. Lee1 1Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital, 2Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, 3Center for Clinical and Translational Research, Nationwide Children's Hospital Research Institute JoVE 58237 Immunology and Infection
Expansión, purificación y evaluación funcional de la sangre periférica humana células NK Srinivas S. Somanchi1, Vladimir V. Senyukov1, Cecele J. Denman1, Dean A. Lee1 1Division of Pediatrics, MD Anderson Cancer Center - University of Texas JoVE 2540 Immunology and Infection